Will McKesson ( MCK ) Beat Estimates Again in Its Next Earnings Report?
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
McKesson ( MCK ) Stock Slides as Market Rises: Facts to Know Before You Trade
In the closing of the recent trading day, McKesson (MCK) stood at $738.06, denoting a -2.72% move from the preceding trading day.
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why McKesson ( MCK ) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
McKesson ( MCK ) Dips More Than Broader Market: What You Should Know
McKesson (MCK) reached $736.52 at the closing of the latest trading day, reflecting a -3.16% change compared to its last close.
Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today - McKesson ( NYSE:MCK )
McKesson ( NYSE: MCK ) has outperformed the market over the past 20 years by 5.87% on an annualized basis producing an average annual return of 14.69%. Currently, McKesson has a market capitalization of $91.61 billion.
Here is What to Know Beyond Why McKesson Corporation ( MCK ) is a Trending Stock
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson ( MCK ) Rises Higher Than Market: Key Facts
The latest trading day saw McKesson (MCK) settling at $698.31, representing a +1.19% change from its previous close.
McKesson ( MCK ) Outperforms Broader Market: What You Need to Know
The latest trading day saw McKesson (MCK) settling at $719.8, representing a +1.92% change from its previous close.
Is Trending Stock McKesson Corporation ( MCK ) a Buy Now?
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Here's How Much $100 Invested In McKesson 5 Years Ago Would Be Worth Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 5 years by 21.84% on an annualized basis producing an average annual return of 35.72%. Currently, McKesson has a market capitalization of $86.44 billion.
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 20 years by 5.74% on an annualized basis producing an average annual return of 14.38%. Currently, McKesson has a market capitalization of $84.68 billion.
Is Most-Watched Stock McKesson Corporation ( MCK ) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.
Cardinal Health to Acquire Solaris Health for Urology Expansion
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
Here's How Much $100 Invested In McKesson 5 Years Ago Would Be Worth Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 5 years by 20.42% on an annualized basis producing an average annual return of 34.18%. Currently, McKesson has a market capitalization of $84.15 billion.
McKesson Corporation ( MCK ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies
Despite tariff headwinds and softer elective procedure demand, McKesson, Cardinal Health, West Pharmaceutical Services, and The Cooper Companies are positioned for steady gains in the dental supplies space.
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Pharmacy Profiles to provide credential verification services for McKesson's Health Mart pharmacies
WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- Pharmacy Profiles, the trusted source for pharmacist identity and credentialing services, today announced a new agreement with McKesson Corporation to provide credential verification services for McKesson's Health Mart independent pharmacy network.
Here's Why McKesson ( MCK ) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal fourth-quarter revenues despite an uncertain macroeconomic environment.
Dividend Watch: 3 Companies Boosting Payouts
Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View
McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.
McKesson ( MCK ) Surpasses Q1 Earnings and Revenue Estimates
McKesson (MCK) delivered earnings and revenue surprises of +0.36% and +1.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?
BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?
MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results?
COR benefits from strong specialty and GLP-1 demand, but Q3 results may face pressure from international weakness.
Disney & 3 Other Stocks With Strong Interest Coverage to Buy Now
DIS, BJ, RL, and MCK stand out with strong interest coverage ratios, making them attractive picks in a volatile market.
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
XRAY's Imaging strength and SureSmile growth might have lifted Q2 performance, but Byte's drag and macro pressures likely clouded the top-line momentum.
$100 Invested In McKesson 5 Years Ago Would Be Worth This Much Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 5 years by 21.3% on an annualized basis producing an average annual return of 34.8%. Currently, McKesson has a market capitalization of $87.28 billion.
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
HIMS' second-quarter 2025 results are likely to benefit from subscriber momentum and digital care tools.
Unlocking Q1 Potential of McKesson ( MCK ) : Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of McKesson (MCK) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Why McKesson ( MCK ) Dipped More Than Broader Market Today
McKesson (MCK) reached $693.54 at the closing of the latest trading day, reflecting a -2.99% change compared to its last close.
Earnings Preview: Becton Dickinson ( BDX ) Q3 Earnings Expected to Decline
Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Conmed ( CNMD ) Q2 Earnings and Revenues Top Estimates
Conmed (CNMD) delivered earnings and revenue surprises of +1.77% and +0.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson ( MCK ) Earnings Expected to Grow: Should You Buy?
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Why Growth Investors Shouldn't Overlook McKesson ( MCK )
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Medical Stocks Lagging McKesson ( MCK ) This Year?
Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About McKesson ( MCK ) : Should You Buy?
The average brokerage recommendation (ABR) for McKesson (MCK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Strength Seen in ProDex ( PDEX ) : Can Its 8.2% Jump Turn into More Strength?
ProDex (PDEX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
How Do Investors Really Feel About McKesson? - McKesson ( NYSE:MCK )
McKesson's MCK short percent of float has risen 6.21% since its last report. The company recently reported that it has 2.13 million shares sold short, which is 1.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.58 days to cover their ...
McKesson Corporation ( MCK ) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here's Why McKesson ( MCK ) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
